Peripheral blood level alterations of TIMP‐1, MMP‐2 and MMP‐9 in patients with Type 1 diabetes

Diabetic Medicine - Tập 18 Số 10 - Trang 777-780 - 2001
Paul R. Maxwell1, Peter Timms, Suresh Chandran, Gordon Murray
1Department of Biochemistry Stobhill Hospital, Glasgow, Glasgow, UK. [email protected]

Tóm tắt

AbstractAim  To determine the plasma levels of enzymes and inhibitors involved in extracellular matrix turnover in patients with Type 1 diabetes with normal renal function.Methods  Plasma levels of matrix metalloproteinases 2 and 9 (MMP‐2, MMP‐9) and tissue inhibitor of metalloproteinase 1 (TIMP‐1) were measured in 43 Type 1 diabetic subjects and age‐ and sex‐matched controls.Results  No significant difference in plasma MMP‐2 between diabetic patients and controls was observed. MMP‐9 was detected in the plasma of 15 diabetic patients (35%), but undetectable in all control subjects (P < 0.015). Plasma TIMP‐1 concentrations were significantly elevated (P < 0.001) in diabetic patients compared to controls. There was no correlation observed between MMP‐2, MMP‐9 and TIMP‐1 and similarly between MMP‐2, MMP‐9 and TIMP‐1 and age, duration of diabetes, blood pressure and glycated haemoglobin (HbA1c).Conclusions  This study has demonstrated alterations in several plasma extracellular matrix modulators in the absence of significant vascular disease.Diabet. Med. 18, 777–780 (2001)

Từ khóa


Tài liệu tham khảo

10.2337/diabetes.25.7.604

10.1007/BF00274536

10.1007/BF02009653

Thorstensson H, 1995, Periodontal disease in adult insulin‐dependent diabetics, Swed Dent J, 107, 1

10.1016/S0046-8177(75)80110-9

10.1007/BF00399925

10.1111/j.1749-6632.1994.tb24724.x

10.3109/15419069609010765

10.1038/ki.1994.345

10.1159/000045052

10.1159/000147926

10.1007/s001250050848

10.1111/j.1464-5491.1992.tb01798.x

10.1016/0891-6632(91)90071-V

10.1023/A:1026630129025

10.1016/0024-3205(96)00099-9

10.1161/01.CIR.98.6.535

10.1016/S0272-6386(98)70015-0

Das A, 1999, Human diabetic neovascular membranes contain high levels of urokinase and metalloproteinase enzymes, Invest Ophthalmol Vis Sci, 40, 809

Zaoui P, 2000, Role of metalloproteases and inhibitors in the occurrence and progression of diabetic renal lesions, Diabetes Metab, 26, 25

Marti HP, 2000, Role of matrix metalloproteinases in the progression of renal lesions, Presse Med, 29, 811

Nakamura T, 1995, Enalapril attenuates increased gene expression of extracellular matrix components in diabetic rats, J Am Soc Nephrol, 5, 1492, 10.1681/ASN.V571492

Wilhelm SM, 1989, SV40 transformed human lung fibroblasts secrete a 92‐kDa type IV collagenase which is identical to that secreted by normal human macrophages, J Biol Chem, 264, 17, 10.1016/S0021-9258(18)71480-4

10.1021/bi00496a016

Thông tin
Thông tin xuất bản

Diabetic Medicine

Tập 18 Số 10

777-780

Thông tin tác giả